Cervical cancer screening test performance has been hampered by either lack of sensitivity of Pap cytology or lack of specificity of Human Papillomavirus (HPV) testing. This uncertainty can lead to unnecessary referral and treatment, which is disturbing for patients and increases costs for health care providers. The identification of p16INK4a as a marker …
UTI Knowledge Center
Knowledge Center
The clinical impact of using p16INK4a immunochemistry in cervical histopathology and cytology: An update of recent developments
Ready to see what better diagnostics can do for your practice?
Talk to a Pathnostics representative about Guidance® UTI and our other tests.